Covance Clinical Research Unit, Inc.,

Madison, Wisconsin 53704-2526

0 studies enrolling now · 47 studies all time

What they study most

ABSORPTION, Accelerated Intimal Hyperplasia, Age-related Macular Degeneration, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Cancer, Dementias With Lewy Bodies, EXCRETION, Healthy, Healthy Adults, Healthy Male Participants, Healthy Male Subjects, Healthy Participants

Studies at this site

• Mass Balance Study of KBP-5074 in Healthy Male Subjects — Completed
• A Study to Evaluate the Effect of Injection Site on PK of Astegolimab in Healthy Subjects — Completed
• Study of H2 Antagonist and a Proton Pump Inhibitor of Selpercatinib in Healthy Participants — Completed
• Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356 — Completed
• A Study to Assess the Mass Balance Recovery (Absorption, Distribution, Metabolism and Excretion) of [14C]CCX168 in Healthy Participants — Completed
• A Study To Investigate The Safety, Tolerability And Pharmacokinetics (PK) Of RO7223280 Following Intravenous Administration In Healthy Participants — Completed
• Bioavailability and Bioequivalence of Two Risdiplam Tablets in Healthy Participants — Completed
• A Study of the Absorption, Metabolism, and Excretion of [14C]-AMG 510 Following a Single Oral Dose in Healthy Male Subjects — Completed
• A Study to Explore the Effect of Acid-reducing Agents — Completed
• QA102 Phase 1 Study in Healthy Young and Older Adult Subjects — Completed
• A Study to Evaluate the Metabolism and Excretion of [14C]-CC-90009 in Healthy Male Subjects — Completed
• A Study to Evaluate the Metabolism and Excretion of [14C]-CC-92480 in Healthy Male Participants — Completed
• Study to Evaluate Bioavailability of Apremilast Oral Suspension Relative to Tablet and to Assess Effect of Food on the Pharmacokinetics (PK) of the Oral Suspension — Completed
• A Study to Evaluate the Pharmacokinetic Exposure of 2 Formulations of Apremilast in Healthy Adults — Completed
• Metabolism and Excretion of [14C]CC-90001 in Healthy Male Subjects — Completed
• AME (Absorption, Metabolism, and Excretion) of Radiolabeled SSP-004184 — Completed
• Study to Evaluate Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast in Healthy Men — Completed
• A Study to Evaluate the Effect of [14C]Acp-196 (Acalabrutinib) in Healthy Adult Participants — Completed
• A Study of [¹⁴C]-LY3202626 in Healthy Male Participants — Completed
• Study of the Absorption, Metabolism, and Excretion Following a Single Dose of [14C]-Poziotinib in Healthy Male Subjects — Completed
• An Open-label Trial to Evaluate Mass Balance of Tavapadon at Steady State in Healthy Subjects — Completed
• Study of the Absorption, Metabolism, and Excretion of [14C]-Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) Following a Single Oral Dose in Healthy Male Subjects — Completed
• The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects — Completed
• A Study to Determine the Metabolism and Elimination of [14C]E2027 in Healthy Male Participants — Completed
• Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-BGB-3111 in Healthy Males — Completed
• Study to Evaluate Absorption, Metabolism and Excretion of Single-dose [14C]-Saroglitazar in Healthy Male Subjects — Completed
• Radiolabeled Study of CC-122 in Healthy Subjects — Completed
• A Safety and Pharmacokinetic Study of AG-881 in Healthy Male Participants Following Administration of a Single Oral Dose of [14C] AG-881 and Concomitant Intravenous Microdose of [13C315N3] AG-881 — Completed
• Pharmacokinetic and Metabolism of [14^C] BMS-986177 in Healthy Male Participants — Completed
• A Drug-Drug Interaction Study Between GDC-0853 and Midazolam, Itraconazole, Rosuvastatin, and Simvastatin — Completed
• A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Praliciguat in Healthy Male Volunteers — Completed
• A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Olinciguat in Healthy Male Volunteers — Completed
• Study Investigating a Single Oral Dose of Fenebrutinib in Healthy Volunteers — Completed
• Single-dose Study of [14C]PF-05221304 Metabolism and Excretion in Healthy Adult Male Subjects — Completed
• A Study to Compare Pharmacokinetics (PK) of Etrolizumab Administered Subcutaneously by a Prefilled Syringe With Needle Safety Device (PFS-NSD) or an Auto-injector (AI) — Completed
• Pharmacokinetics and Metabolism Study in Healthy Male Participants — Completed
• Single-dose Study of [14C]Lorlatinib (PF-06463922) Metabolism In Healthy Male Volunteers — Completed
• Metabolism and Excretion of [14C]-Rigosertib After Infusion to Volunteers — Completed
• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7079901 and the Combination of RO7079901 With Meropenem in Adult Healthy Volunteers — Completed
• Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects — Completed
• An Open-label, Single Dose Study to Determine the Metabolism and Elimination of [14C]E2609 in Healthy Male Subjects — Completed
• A Study To Investigate The Absorption, Distribution, Metabolism, And Excretion Of [14c]PF-06463922 In Healthy Male Volunteers — Completed
• An Open-Label, Single-Dose Study to Determine the Metabolism and Elimination of 14C-Perampanel in Healthy Male Subjects — Completed
• A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986104 in Healthy Male Subjects — Completed
• Investigate Absorption, Metabolism and Excretion of [14C}-Proellex Following Single Oral Dose in Healthy Females — Completed
• A Phase 1 Study to Evaluate The Effect of Ketoconazole on the Pharmacokinetics of Tivozanib in Healthy Subjects — Completed
• Single Ascending Dose (BMS-813160) Study — Completed